ACS Publications. Most Trusted. Most Cited. Most Read
My Activity
CONTENT TYPES

Figure 1Loading Img

Structure-Based Macrocycle Design in Small-Molecule Drug Discovery and Simple Metrics To Identify Opportunities for Macrocyclization of Small-Molecule Ligands

Cite this: J. Med. Chem. 2019, 62, 15, 6843–6853
Publication Date (Web):March 12, 2019
https://doi.org/10.1021/acs.jmedchem.8b01985
Copyright © 2019 American Chemical Society

    Article Views

    9366

    Altmetric

    -

    Citations

    77
    LEARN ABOUT THESE METRICS
    Other access options

    Abstract

    Abstract Image

    Interest is growing in the use of macrocycles in pharmaceutical discovery. Macrocylization may provide a gateway to an expanded chemical space for small-molecule drug discovery, and this could be beneficial in prosecuting difficult targets, e.g., protein–protein interactions. Most, but not all, macrocycle drugs are derived from natural products. Studies on synthetic drug-like small-molecule macrocycles are limited, and our current understanding of macrocycle drugs is similarly limited. Following some background discussion, we review several examples of the structure-based design of synthetic macrocycles. Our opinion is that in conformationally suitable systems macrocycles are an analog class worthy of consideration. We then summarize an approach for the initial evaluation of molecules as candidates for macrocyclization.

    Read this article

    To access this article, please review the available access options below.

    Get instant access

    Purchase Access

    Read this article for 48 hours. Check out below using your ACS ID or as a guest.

    Recommended

    Access through Your Institution

    You may have access to this article through your institution.

    Your institution does not have access to this content. You can change your affiliated institution below.

    Cited By

    This article is cited by 77 publications.

    1. Marion G. Götz, Kacey Godwin, Rachel Price, Robert Dorn, Gabriel Merrill-Steskal, William Klemmer, Hunter Hansen, Gautam Produturi, Megan Rocha, Mathias Palmer, Lea Molacek, Zack Strater, Michael Groll. Macrocyclic Oxindole Peptide Epoxyketones─A Comparative Study of Macrocyclic Inhibitors of the 20S Proteasome. ACS Medicinal Chemistry Letters 2024, 15 (4) , 533-539. https://doi.org/10.1021/acsmedchemlett.4c00017
    2. Jihua Zou, Jianyu Yan, Yifei Lu, Zhou Yu, Kai Zhang, Qianyu Han, Dan Han, Conghao Gai, Xiaoyun Chai, Qingjie Zhao, Chunlin Zhuang, Yan Zou. Cyclic Peptide Keap1–Nrf2 Protein–Protein Interaction Inhibitors: Design, Synthesis, and In Vivo Treatment of Acute Lung Injury. Journal of Medicinal Chemistry 2024, 67 (6) , 4889-4903. https://doi.org/10.1021/acs.jmedchem.4c00065
    3. Zheng Zhao, Philip E. Bourne. Rigid Scaffolds Are Promising for Designing Macrocyclic Kinase Inhibitors. ACS Pharmacology & Translational Science 2023, 6 (8) , 1182-1191. https://doi.org/10.1021/acsptsci.3c00078
    4. Vadims Kovada, Chrislaine Withers-Martinez, Raitis Bobrovs, Hele̅na Ce̅rule, Edgars Liepins, Solveiga Grinberga, Fiona Hackett, Christine R. Collins, Agrita Kreicberga, María Belén Jiménez-Díaz, Iñigo Angulo-Barturen, Dace Rasina, Edgars Suna, Kristaps Jaudzems, Michael J. Blackman, Aigars Jirgensons. Macrocyclic Peptidomimetic Plasmepsin X Inhibitors with Potent In Vitro and In Vivo Antimalarial Activity. Journal of Medicinal Chemistry 2023, 66 (15) , 10658-10680. https://doi.org/10.1021/acs.jmedchem.3c00812
    5. Ziquan Zhao, Ruitian Dong, Qidong You, Zhengyu Jiang. Medicinal Chemistry Insights into the Development of Small-Molecule Kelch-Like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1–Nrf2) Protein–Protein Interaction Inhibitors. Journal of Medicinal Chemistry 2023, 66 (14) , 9325-9344. https://doi.org/10.1021/acs.jmedchem.3c00712
    6. Jing Chai, Christopher C. Arico-Muendel, Yun Ding, Michael P. Pollastri, Sarah Scott, Mark A. Mantell, Gang Yao. Synthesis of a DNA-Encoded Macrocyclic Library Utilizing Intramolecular Benzimidazole Formation. Bioconjugate Chemistry 2023, 34 (6) , 988-993. https://doi.org/10.1021/acs.bioconjchem.3c00159
    7. Diego Garcia Jimenez, Vasanthanathan Poongavanam, Jan Kihlberg. Macrocycles in Drug Discovery─Learning from the Past for the Future. Journal of Medicinal Chemistry 2023, 66 (8) , 5377-5396. https://doi.org/10.1021/acs.jmedchem.3c00134
    8. Yang Yu, Junhong Huang, Hu He, Jing Han, Geyan Ye, Tingyang Xu, Xianqiang Sun, Xiumei Chen, Xiaoming Ren, Chunlai Li, Huijuan Li, Wei Huang, Yangyang Liu, Xinjuan Wang, Yongzhi Gao, Nianhe Cheng, Na Guo, Xibo Chen, Jianxia Feng, Yuxia Hua, Chong Liu, Guoyun Zhu, Zhi Xie, Lili Yao, Wenge Zhong, Xinde Chen, Wei Liu, Hailong Li. Accelerated Discovery of Macrocyclic CDK2 Inhibitor QR-6401 by Generative Models and Structure-Based Drug Design. ACS Medicinal Chemistry Letters 2023, 14 (3) , 297-304. https://doi.org/10.1021/acsmedchemlett.2c00515
    9. Ming-Shu Wang, Zhi-Zheng Wang, Zi-Long Li, Yi Gong, Cheng-Xiang Duan, Qian-Hui Cheng, Wei Huang, Guang-Fu Yang. Discovery of Macrocycle-Based HPK1 Inhibitors for T-Cell-Based Immunotherapy. Journal of Medicinal Chemistry 2023, 66 (1) , 611-626. https://doi.org/10.1021/acs.jmedchem.2c01551
    10. Dan Sindhikara Jennifer Johnston . Roles of Conformations on Predictions of Peptide Properties. , 103-135. https://doi.org/10.1021/bk-2022-1417.ch004
    11. Alessandra Salerno, Francesca Seghetti, Jessica Caciolla, Elisa Uliassi, Eleonora Testi, Melissa Guardigni, Marinella Roberti, Andrea Milelli, Maria Laura Bolognesi. Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One. Journal of Medicinal Chemistry 2022, 65 (14) , 9507-9530. https://doi.org/10.1021/acs.jmedchem.2c00302
    12. Andrew D. Cansfield, Mark A. Ator, Joydeep Banerjee, Michael Bestwick, Andrea Bortolato, Giles A. Brown, Jason Brown, Kristina Butkovic, Julie E. Cansfield, John A. Christopher, Miles Congreve, Gabriella Cseke, Francesca Deflorian, Benjamin Dugan, Martina Petrovic Hunjadi, Antun Hutinec, Trinadh Kumar Inturi, Goran Landek, Jonathan Mason, Alistair O’Brien, Gregory R. Ott, Renata Rupcic, Gordon Saxty, Stacey M. Southall, Rahela Zadravec, Stephen P. Watson. Novel Macrocyclic Antagonists of the Calcitonin Gene-Related Peptide Receptor: Design, Realization, and Structural Characterization of Protein–Ligand Complexes. ACS Chemical Neuroscience 2022, 13 (6) , 751-765. https://doi.org/10.1021/acschemneuro.1c00696
    13. Abigail N. Smith, Daniel J. Blackwell, Bjorn C. Knollmann, Jeffrey N. Johnston. Ring Size as an Independent Variable in Cyclooligomeric Depsipeptide Antiarrhythmic Activity. ACS Medicinal Chemistry Letters 2021, 12 (12) , 1942-1947. https://doi.org/10.1021/acsmedchemlett.1c00508
    14. Hao Zhang, Hao-Chi Hsu, Shoshanna C. Kahne, Ryoma Hara, Wenhu Zhan, Xiuju Jiang, Kristin Burns-Huang, Tierra Ouellette, Toshihiro Imaeda, Rei Okamoto, Masanori Kawasaki, Mayako Michino, Tzu-Tshin Wong, Akinori Toita, Takafumi Yukawa, Francesca Moraca, Jeremie Vendome, Priya Saha, Kenjiro Sato, Kazuyoshi Aso, John Ginn, Peter T. Meinke, Michael Foley, Carl F. Nathan, K. Heran Darwin, Huilin Li, Gang Lin. Macrocyclic Peptides that Selectively Inhibit the Mycobacterium tuberculosis Proteasome. Journal of Medicinal Chemistry 2021, 64 (9) , 6262-6272. https://doi.org/10.1021/acs.jmedchem.1c00296
    15. Xi Xu, Jubo Wang, Min Wang, Xinyu Yuan, Lei Li, Chao Zhang, Huidan Huang, Tian Jing, Chenchen Wang, Chao Tong, Liwen Zhou, Ying Meng, Pengfei Xu, Junping Kou, Zhixia Qiu, Zhiyu Li, Jinlei Bian. Structure-Enabled Discovery of Novel Macrocyclic Inhibitors Targeting Glutaminase 1 Allosteric Binding Site. Journal of Medicinal Chemistry 2021, 64 (8) , 4588-4611. https://doi.org/10.1021/acs.jmedchem.0c02044
    16. Dan Liu, Nan Jiang, Wen Dou Huang, Ji Wen Li, Wen Jing Zhu, Ren Xiang Tan. Ionic-Liquid-Catalyzed Access to CTr: An Antitumor Agent. ACS Sustainable Chemistry & Engineering 2021, 9 (14) , 5138-5147. https://doi.org/10.1021/acssuschemeng.1c00191
    17. Michael Bauder, Christian Meyners, Patrick L. Purder, Stephanie Merz, Wisely Oki Sugiarto, Andreas M. Voll, Tim Heymann, Felix Hausch. Structure-Based Design of High-Affinity Macrocyclic FKBP51 Inhibitors. Journal of Medicinal Chemistry 2021, 64 (6) , 3320-3349. https://doi.org/10.1021/acs.jmedchem.0c02195
    18. David S. Peters, Cody Ross Pitts, Kyle S. McClymont, Thomas P. Stratton, Cheng Bi, Phil S. Baran. Ideality in Context: Motivations for Total Synthesis. Accounts of Chemical Research 2021, 54 (3) , 605-617. https://doi.org/10.1021/acs.accounts.0c00821
    19. Hao Chen, Jeff B. Smaill, Tongzheng Liu, Ke Ding, Xiaoyun Lu. Small-Molecule Inhibitors Directly Targeting KRAS as Anticancer Therapeutics. Journal of Medicinal Chemistry 2020, 63 (23) , 14404-14424. https://doi.org/10.1021/acs.jmedchem.0c01312
    20. Dan Sindhikara, Michael Wagner, Paraskevi Gkeka, Stefan Güssregen, Garima Tiwari, Gerhard Hessler, Engin Yapici, Ziyu Li, Andreas Evers. Automated Design of Macrocycles for Therapeutic Applications: From Small Molecules to Peptides and Proteins. Journal of Medicinal Chemistry 2020, 63 (20) , 12100-12115. https://doi.org/10.1021/acs.jmedchem.0c01500
    21. Shuzhe Wang, Jagna Witek, Gregory A. Landrum, Sereina Riniker. Improving Conformer Generation for Small Rings and Macrocycles Based on Distance Geometry and Experimental Torsional-Angle Preferences. Journal of Chemical Information and Modeling 2020, 60 (4) , 2044-2058. https://doi.org/10.1021/acs.jcim.0c00025
    22. Radka Houštecká, Martin Hadzima, Jindřich Fanfrlík, Jiří Brynda, Lenka Pallová, Iva Hánová, Helena Mertlíková-Kaiserová, Martin Lepšík, Martin Horn, Martin Smrčina, Pavel Majer, Michael Mareš. Biomimetic Macrocyclic Inhibitors of Human Cathepsin D: Structure–Activity Relationship and Binding Mode Analysis. Journal of Medicinal Chemistry 2020, 63 (4) , 1576-1596. https://doi.org/10.1021/acs.jmedchem.9b01351
    23. Amber Y. S. Balazs, Rodrigo J. Carbajo, Nichola L. Davies, Yu Dong, Alexander W. Hird, Jeffrey W. Johannes, Michelle L. Lamb, William McCoull, Piotr Raubo, Graeme R. Robb, Martin J. Packer, Elisabetta Chiarparin. Free Ligand 1D NMR Conformational Signatures To Enhance Structure Based Drug Design of a Mcl-1 Inhibitor (AZD5991) and Other Synthetic Macrocycles. Journal of Medicinal Chemistry 2019, 62 (21) , 9418-9437. https://doi.org/10.1021/acs.jmedchem.9b00716
    24. Christopher J. M. Brown, Michael P. Gotsbacher, Jason P. Holland, Rachel Codd. endo-Hydroxamic Acid Monomers for the Assembly of a Suite of Non-native Dimeric Macrocyclic Siderophores Using Metal-Templated Synthesis. Inorganic Chemistry 2019, 58 (20) , 13591-13603. https://doi.org/10.1021/acs.inorgchem.9b00878
    25. Fanye Meng, Jinxin Liu, Zhongying Cao, Jiaojiao Yu, Barbara Steurer, Yilin Yang, Yazhou Wang, Xin Cai, Man Zhang, Feng Ren, Alex Aliper, Xiao Ding, Alex Zhavoronkov. Discovery of macrocyclic CDK2/4/6 inhibitors with improved potency and DMPK properties through a highly efficient macrocyclic drug design platform. Bioorganic Chemistry 2024, 146 , 107285. https://doi.org/10.1016/j.bioorg.2024.107285
    26. Pedro Henrique Oliveira Borges, Sabrina Baptista Ferreira, Floriano Paes Silva. Recent Advances on Targeting Proteases for Antiviral Development. Viruses 2024, 16 (3) , 366. https://doi.org/10.3390/v16030366
    27. Baku Acharya, Debasmita Saha, Daniel Armstrong, Baha'a Jabali, Maha Hanafi, Alan Herrera-Rueda, Naga Rajiv Lakkaniga, Brendan Frett. Kinase inhibitor macrocycles: a perspective on limiting conformational flexibility when targeting the kinome with small molecules. RSC Medicinal Chemistry 2024, 15 (2) , 399-415. https://doi.org/10.1039/D3MD00457K
    28. Will E. Orukotan, Kleopas Y. Palate, Balázs Pogrányi, Philipp Bobinski, Ryan G. Epton, Lee Duff, Adrian C. Whitwood, Gideon Grogan, Jason M. Lynam, William P. Unsworth. Divergent Cascade Ring‐Expansion Reactions of Acryloyl Imides. Chemistry – A European Journal 2024, 30 (8) https://doi.org/10.1002/chem.202303270
    29. Jack M. Wootton, Jerry K. F. Tam, William P. Unsworth. Cascade ring expansion reactions for the synthesis of medium-sized rings and macrocycles. Chemical Communications 2024, 38 https://doi.org/10.1039/D4CC01303D
    30. Jing Guo, Yang Zhou, Xiaoyun Lu. Advances in protein kinase drug discovery through targeting gatekeeper mutations. Expert Opinion on Drug Discovery 2023, 18 (12) , 1349-1366. https://doi.org/10.1080/17460441.2023.2265303
    31. Yanyan Diao, Dandan Liu, Huan Ge, Rongrong Zhang, Kexin Jiang, Runhui Bao, Xiaoqian Zhu, Hongjie Bi, Wenjie Liao, Ziqi Chen, Kai Zhang, Rui Wang, Lili Zhu, Zhenjiang Zhao, Qiaoyu Hu, Honglin Li. Macrocyclization of linear molecules by deep learning to facilitate macrocyclic drug candidates discovery. Nature Communications 2023, 14 (1) https://doi.org/10.1038/s41467-023-40219-8
    32. Marilia Barreca, Yuting Qin, Marie Elodie Hélène Cadot, Paola Barraja, Anders Bach. Advances in developing noncovalent small molecules targeting Keap1. Drug Discovery Today 2023, 28 (12) , 103800. https://doi.org/10.1016/j.drudis.2023.103800
    33. . ALK/multikinase Inhibitors. 2023, 195-213. https://doi.org/10.1002/9781394207145.ch9
    34. Yi-Ru Bai, Wei-Guang Yang, Xue-Hui Hou, Dan-Dan Shen, Sheng-Nan Zhang, Yan Li, Yan-Yan Qiao, Sai-Qi Wang, Shuo Yuan, Hong-Min Liu. The recent advance of Interleukin-1 receptor associated kinase 4 inhibitors for the treatment of inflammation and related diseases. European Journal of Medicinal Chemistry 2023, 258 , 115606. https://doi.org/10.1016/j.ejmech.2023.115606
    35. Isabela Ramirez-Velez, Brian Belardi. Storming the gate: New approaches for targeting the dynamic tight junction for improved drug delivery. Advanced Drug Delivery Reviews 2023, 199 , 114905. https://doi.org/10.1016/j.addr.2023.114905
    36. Shraddha Parate, Vikas Kumar, Jong Chan Hong, Keun Woo Lee. Investigation of Macrocyclic mTOR Modulators of Rapamycin Binding Site via Pharmacoinformatics Approaches. Computational Biology and Chemistry 2023, 104 , 107875. https://doi.org/10.1016/j.compbiolchem.2023.107875
    37. Jiayou Cai, Bin Sun, Siqi Yu, Han Zhang, Weicheng Zhang. Heck Macrocyclization in Forging Non-Natural Large Rings including Macrocyclic Drugs. International Journal of Molecular Sciences 2023, 24 (9) , 8252. https://doi.org/10.3390/ijms24098252
    38. Bichao Song, Xueying Guo, Li Yang, Haiyue Yu, Xinlei Zong, Xiujuan Liu, Hao Wang, Zhongliang Xu, Zhenyang Lin, Weibo Yang. Rhodium(III)‐Catalyzed C‐H/O 2 Dual Activation and Macrocyclization: Synthesis and Evaluation of Pyrido[2,1‐a]isoindole Grafted Macrocyclic Inhibitors for Influenza H1N1. Angewandte Chemie 2023, 135 (15) https://doi.org/10.1002/ange.202218886
    39. Bichao Song, Xueying Guo, Li Yang, Haiyue Yu, Xinlei Zong, Xiujuan Liu, Hao Wang, Zhongliang Xu, Zhenyang Lin, Weibo Yang. Rhodium(III)‐Catalyzed C‐H/O 2 Dual Activation and Macrocyclization: Synthesis and Evaluation of Pyrido[2,1‐a]isoindole Grafted Macrocyclic Inhibitors for Influenza H1N1. Angewandte Chemie International Edition 2023, 62 (15) https://doi.org/10.1002/anie.202218886
    40. Siddharth Yadav, Shahzaib Ahamad, Dinesh Gupta, Puniti Mathur. Lead optimization, pharmacophore development and scaffold design of protein kinase CK2 inhibitors as potential COVID-19 therapeutics. Journal of Biomolecular Structure and Dynamics 2023, 41 (5) , 1811-1827. https://doi.org/10.1080/07391102.2021.2024449
    41. Zhongzhen Yang, Illya Zalessky, Ryan G. Epton, Adrian C. Whitwood, Jason M. Lynam, William P. Unsworth. Ring Expansion Strategies for the Synthesis of Medium Sized Ring and Macrocyclic Sulfonamides. Angewandte Chemie 2023, 135 (13) https://doi.org/10.1002/ange.202217178
    42. Zhongzhen Yang, Illya Zalessky, Ryan G. Epton, Adrian C. Whitwood, Jason M. Lynam, William P. Unsworth. Ring Expansion Strategies for the Synthesis of Medium Sized Ring and Macrocyclic Sulfonamides. Angewandte Chemie International Edition 2023, 62 (13) https://doi.org/10.1002/anie.202217178
    43. Antonio Greco, Claudio Laudani, Marco Spagnolo, Federica Agnello, Denise Cristiana Faro, Simone Finocchiaro, Marco Legnazzi, Maria Sara Mauro, Placido Maria Mazzone, Giovanni Occhipinti, Carla Rochira, Lorenzo Scalia, Davide Capodanno. Pharmacology and Clinical Development of Factor XI Inhibitors. Circulation 2023, 147 (11) , 897-913. https://doi.org/10.1161/CIRCULATIONAHA.122.062353
    44. Hao Wang, Zhongyu Li, Xiangyang Chen, Jonathan J. Wong, Tongyu Bi, Xiankun Tong, Zhongliang Xu, Mingyue Zhen, Yunhui Wan, Li Tang, Bo Liu, Xinlei Zong, Dandan Xu, Jianping Zuo, Li Yang, Wei Huang, Kendall N. Houk, Weibo Yang. Multicomponent coupling and macrocyclization enabled by Rh(III)-catalyzed dual C–H activation: Macrocyclic oxime inhibitor of influenza H1N1. Chem 2023, 9 (3) , 607-623. https://doi.org/10.1016/j.chempr.2022.10.019
    45. Mounir Cherfi, Tarik Harit, Fouad Malek. New macrocycles based on pyrazole-tetrazole subunit: synthesis, characterization and their complexing properties toward heavy metal cations. Journal of Inclusion Phenomena and Macrocyclic Chemistry 2023, 103 (1-2) , 63-70. https://doi.org/10.1007/s10847-023-01177-2
    46. Geshuyi Chen, Zhe Chang, Pei Yuan, Si Wang, Yongxiu Yang, Xiaolei Liang, Depeng Zhao. Late-stage functionalization of 5-nitrofurans derivatives and their antibacterial activities. RSC Advances 2023, 13 (5) , 3204-3209. https://doi.org/10.1039/D2RA07676D
    47. Ziquan Zhao, Ruitian Dong, Keni Cui, Qidong You, Zhengyu Jiang. An updated patent review of Nrf2 activators (2020-present). Expert Opinion on Therapeutic Patents 2023, 33 (1) , 29-49. https://doi.org/10.1080/13543776.2023.2178299
    48. Yanyan Diao, Feng Hu, Zihao Shen, Honglin Li, . MacFrag: segmenting large-scale molecules to obtain diverse fragments with high qualities. Bioinformatics 2023, 39 (1) https://doi.org/10.1093/bioinformatics/btad012
    49. Durgesh Kumar, Kamlesh Kumari, Ramesh Chandra, Pallavi Jain, Lata Vodwal, Geetu Gambhir, Prashant Singh. A review targeting the infection by CHIKV using computational and experimental approaches. Journal of Biomolecular Structure and Dynamics 2022, 40 (17) , 8127-8141. https://doi.org/10.1080/07391102.2021.1904004
    50. Alessio Ciulli, Oliver Hsia. PROTAC Degraders. 2022, 317-356. https://doi.org/10.1002/9781119774198.ch9
    51. Xiang Qi, Songwei Jiang, Zi Hui, Yuan Gao, Yang Ye, Frédéric Lirussi, Carmen Garrido, Li Xu, Xingrui He, Renren Bai, Xiang-Yang Ye, Tian Xie. Design, synthesis and antitumor efficacy evaluation of a series of novel β-elemene-based macrocycles. Bioorganic & Medicinal Chemistry 2022, 74 , 117049. https://doi.org/10.1016/j.bmc.2022.117049
    52. Vinduja Puthanveedu, Karuvanthodi Muraleedharan. Phytochemicals as potential inhibitors for COVID-19 revealed by molecular docking, molecular dynamic simulation and DFT studies. Structural Chemistry 2022, 33 (5) , 1423-1443. https://doi.org/10.1007/s11224-022-01982-4
    53. Keisuke Baba, Yasushi Goto. Lorlatinib as a treatment for ALK-positive lung cancer. Future Oncology 2022, 18 (24) , 2745-2766. https://doi.org/10.2217/fon-2022-0184
    54. Marcus Baumann. Synthesis of Bioactive Heterocycles Exploiting Modern Continuous Flow Chemistry. 2022, 411-447. https://doi.org/10.1002/9781119757153.ch12
    55. Melanie Trobe, Martin Vareka, Till Schreiner, Patrick Dobrounig, Carina Doler, Ella B. Holzinger, Andreas Steinegger, Rolf Breinbauer. A Modular Synthesis of Teraryl‐Based α‐Helix Mimetics, Part 3: Iodophenyltriflate Core Fragments Featuring Side Chains of Proteinogenic Amino Acids. European Journal of Organic Chemistry 2022, 2022 (17) https://doi.org/10.1002/ejoc.202101278
    56. Chen Chen, Jun Ge, Ling He. Selective synthesis and reactivity expansion of α,β-unsaturated geminal diazides. Organic Chemistry Frontiers 2022, 9 (8) , 2116-2120. https://doi.org/10.1039/D2QO00008C
    57. Kleopas Y. Palate, Zhongzhen Yang, Adrian C. Whitwood, William P. Unsworth. Synthesis of medium-ring lactams and macrocyclic peptide mimetics via conjugate addition/ring expansion cascade reactions. RSC Chemical Biology 2022, 3 (3) , 334-340. https://doi.org/10.1039/D1CB00245G
    58. Samantha Stone, David J. Newman, Steven L. Colletti, Derek S. Tan. Cheminformatic analysis of natural product-based drugs and chemical probes. Natural Product Reports 2022, 39 (1) , 20-32. https://doi.org/10.1039/D1NP00039J
    59. Hao Wang, Zhongyu Li, Xiangyang Chen, Jonathan Wong, Tongyu Bi, Xiankun Tong, Zhongliang Xu, Mingyue Zheng, Yunhui Wan, Li Tang, Bo Liu, Xinlei Zong, Jianping Zuo, Li Yang, Wei Huang, Kendall N. Houk, Weibo Yang. Nitrene-Mediated Multicomponent Couplings and Macrocyclization by CH-Functionalization. SSRN Electronic Journal 2022, 7 https://doi.org/10.2139/ssrn.4138710
    60. Jiping Hao, Xueying Guo, Shijun He, Zhongliang Xu, Lu Chen, Zhongyu Li, Bichao Song, Jianping Zuo, Zhenyang Lin, Weibo Yang. Marine furanocembranoids-inspired macrocycles enabled by Pd-catalyzed unactivated C(sp3)-H olefination mediated by donor/donor carbenes. Nature Communications 2021, 12 (1) https://doi.org/10.1038/s41467-021-21484-x
    61. Wenting Li, Lun Tan, Zhixiong Zhang, Qiuqi Xia, Dongsheng Lei, Yuyan Li, Ting Zhang, Shaoxue Zeng, Xiutian Sima, Yanyan Wang. The X-ray structure of tubulysin analogue TGL in complex with tubulin and three possible routes for the development of next-generation tubulysin analogues. Biochemical and Biophysical Research Communications 2021, 565 , 29-35. https://doi.org/10.1016/j.bbrc.2021.05.086
    62. Piotr Raubo, Rodrigo J. Carbajo, William McCoull, Joanna Raubo, Morgan Thomas. Diversity-orientated synthesis of macrocyclic heterocycles using a double S N Ar approach. Organic & Biomolecular Chemistry 2021, 19 (28) , 6274-6290. https://doi.org/10.1039/D1OB00612F
    63. Tao Sun, Shijun He, Zhongliang Xu, Jianping Zuo, Yang Yu, Weibo Yang. Rh-Catalyzed C–H alkylation enabling modular synthesis of CF 3 -substituted benzannulated macrocyclic inhibitors of B cell responses. Organic & Biomolecular Chemistry 2021, 19 (16) , 3589-3594. https://doi.org/10.1039/D1OB00296A
    64. Rosa M. Álvarez, Ana Belén García, Concepción Riesco-Fagundo, José I. Martín, Carmen Varela, Antonio Rodríguez Hergueta, Esther González Cantalapiedra, Julen Oyarzabal, Bruno Di Geronimo, Milagros Lorenzo, M Isabel Albarrán, Antonio Cebriá, David Cebrián, Sonia Martínez-González, Carmen Blanco-Aparicio, Joaquín Pastor. Omipalisib inspired macrocycles as dual PI3K/mTOR inhibitors. European Journal of Medicinal Chemistry 2021, 211 , 113109. https://doi.org/10.1016/j.ejmech.2020.113109
    65. Jonathan Bogaerts, Yoseph Atilaw, Stefan Peintner, Roy Aerts, Jan Kihlberg, Christian Johannessen, Máté Erdélyi. Employing complementary spectroscopies to study the conformations of an epimeric pair of side-chain stapled peptides in aqueous solution. RSC Advances 2021, 11 (7) , 4200-4208. https://doi.org/10.1039/D0RA10167B
    66. Lu Chen, Haitian Quan, Zhongliang Xu, Hao Wang, Yuanzhi Xia, Liguang Lou, Weibo Yang. A modular biomimetic strategy for the synthesis of macrolide P-glycoprotein inhibitors via Rh-catalyzed C-H activation. Nature Communications 2020, 11 (1) https://doi.org/10.1038/s41467-020-16084-0
    67. Maximilian J. Hochmair, Hannah Fabikan, Oliver Illini, Christoph Weinlinger, Ulrike Setinek, Dagmar Krenbek, Helmut Prosch, Markus Rauter, Michael Schumacher, Ewald Wöll, Romana Wass, Elmar Brehm, Gudrun Absenger, Tatjana Bundalo, Peter Errhalt, Matthias Urban, Arschang Valipour. Later-Line Treatment with Lorlatinib in ALK- and ROS1-Rearrangement-Positive NSCLC: A Retrospective, Multicenter Analysis. Pharmaceuticals 2020, 13 (11) , 371. https://doi.org/10.3390/ph13110371
    68. Seyed Abolfazl Hosseini–Yazdi, Leila Noohinejad, Hena Kalantari, Azadeh Mirzaahmadi. Anion-directed assemblies of Cu(II) mono, di, and poly-nuclear coordination compounds with a 32-membered azacrown ligand: Synthesis, characterisation and crystal structures. Journal of Molecular Structure 2020, 1215 , 128200. https://doi.org/10.1016/j.molstruc.2020.128200
    69. Ruixiang Cheng, Wenfang Xiong, Chaorong Qi, Lu Wang, Yanwei Ren, Huanfeng Jiang. Macrocyclization of 3-triflyloxybenzynes with tetrahydrofuran via an anionic thia-Fries rearrangement. Chemical Communications 2020, 56 (48) , 6495-6498. https://doi.org/10.1039/D0CC00135J
    70. Xiao Ding, Feng Ren. Leucine-rich repeat kinase 2 inhibitors: a patent review (2014-present). Expert Opinion on Therapeutic Patents 2020, 30 (4) , 275-286. https://doi.org/10.1080/13543776.2020.1729354
    71. Aimee K. Clarke, William P. Unsworth. A happy medium: the synthesis of medicinally important medium-sized rings via ring expansion. Chemical Science 2020, 11 (11) , 2876-2881. https://doi.org/10.1039/D0SC00568A
    72. Saumitra Sengupta, Goverdhan Mehta. Macrocyclization via C–H functionalization: a new paradigm in macrocycle synthesis. Organic & Biomolecular Chemistry 2020, 18 (10) , 1851-1876. https://doi.org/10.1039/C9OB02765C
    73. Rami A. Al-Horani. Factor XI(a) inhibitors for thrombosis: an updated patent review (2016-present). Expert Opinion on Therapeutic Patents 2020, 30 (1) , 39-55. https://doi.org/10.1080/13543776.2020.1705783
    74. Daniel Madsen, Carlos Azevedo, Iolanda Micco, Lars Kolster Petersen, Nils Jakob Vest Hansen. An overview of DNA-encoded libraries: A versatile tool for drug discovery. 2020, 181-249. https://doi.org/10.1016/bs.pmch.2020.03.001
    75. Sarah J. Martin, I-Jen Chen, A.W. Edith Chan, Nicolas Foloppe. Modelling the binding mode of macrocycles: Docking and conformational sampling. Bioorganic & Medicinal Chemistry 2020, 28 (1) , 115143. https://doi.org/10.1016/j.bmc.2019.115143
    76. Yanling Wang, Huan Ge, Disha Wang, Huan He, Lu Li, Yanyan Diao, Zihao Shen, Lili Zhu, Shiliang Li, Zhenjiang Zhao, Honglin Li. Design and Synthesis of a Series of Novel Macrocycle Janus Kinase 2 Inhibitors. Chinese Journal of Chemistry 2019, 37 (12) , 1259-1263. https://doi.org/10.1002/cjoc.201900316
    77. Anna V. Vologzhanina. Intermolecular Interactions in Functional Crystalline Materials: From Data to Knowledge. Crystals 2019, 9 (9) , 478. https://doi.org/10.3390/cryst9090478

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    You’ve supercharged your research process with ACS and Mendeley!

    STEP 1:
    Click to create an ACS ID

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    MENDELEY PAIRING EXPIRED
    Your Mendeley pairing has expired. Please reconnect